Align Technology, Inc. (ALGN)
NASDAQ: ALGN · Real-Time Price · USD
136.86
-2.26 (-1.62%)
At close: Sep 8, 2025, 4:00 PM
137.01
+0.15 (0.11%)
After-hours: Sep 8, 2025, 5:47 PM EDT
Align Technology Revenue
Align Technology had revenue of $1.01B in the quarter ending June 30, 2025, a decrease of -1.56%. This brings the company's revenue in the last twelve months to $3.96B, up 0.56% year-over-year. In the year 2024, Align Technology had annual revenue of $4.00B with 3.54% growth.
Revenue (ttm)
$3.96B
Revenue Growth
+0.56%
P/S Ratio
2.59
Revenue / Employee
$189,296
Employees
20,945
Market Cap
9.92B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.00B | 136.75M | 3.54% |
Dec 31, 2023 | 3.86B | 127.63M | 3.42% |
Dec 31, 2022 | 3.73B | -217.95M | -5.51% |
Dec 31, 2021 | 3.95B | 1.48B | 59.90% |
Dec 31, 2020 | 2.47B | 65.15M | 2.71% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ALGN News
- 5 days ago - Align Technology, Inc. (ALGN) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript - Seeking Alpha
- 11 days ago - Align Technology to Speak at Upcoming Financial Conferences - Business Wire
- 14 days ago - 30 Stocks That Could Rally 30% or More - Kiplinger
- 20 days ago - Align Technology Initiates Patent Infringement Litigation Against Angelalign Technology - Business Wire
- 21 days ago - Align Technology Initiates Patent Infringement Ligitation Against Angelalign Technology - Business Wire
- 4 weeks ago - Align Technology: Q2 Earnings With A Smile, Then A Grimace - Seeking Alpha
- 4 weeks ago - Align Technology Is A Buy: Secular Headwinds Temporary, Market Dominance Enduring - Seeking Alpha
- 4 weeks ago - Align Technology Announces $200 Million Open Market Repurchase - Business Wire